The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.

cmprsk: Subdistribution Analysis of Competing Risks

Estimation, testing and regression modeling of subdistribution functions in competing risks, as described in Gray (1988), A class of K-sample tests for comparing the cumulative incidence of a competing risk, Ann. Stat. 16:1141-1154 <doi:10.1214/aos/1176350951>, and Fine JP and Gray RJ (1999), A proportional hazards model for the subdistribution of a competing risk, JASA, 94:496-509, <doi:10.1080/01621459.1999.10474144>.

Version: 2.2-11
Depends: R (≥ 3.0.0), survival
Published: 2022-01-06
Author: Bob Gray
Maintainer: Bob Gray <gray at jimmy.harvard.edu>
License: GPL-2 | GPL-3 [expanded from: GPL (≥ 2)]
URL: https://www.R-project.org
NeedsCompilation: yes
In views: Epidemiology, Survival
CRAN checks: cmprsk results

Documentation:

Reference manual: cmprsk.pdf

Downloads:

Package source: cmprsk_2.2-11.tar.gz
Windows binaries: r-devel: cmprsk_2.2-11.zip, r-release: cmprsk_2.2-11.zip, r-oldrel: cmprsk_2.2-11.zip
macOS binaries: r-release (arm64): cmprsk_2.2-11.tgz, r-oldrel (arm64): cmprsk_2.2-11.tgz, r-release (x86_64): cmprsk_2.2-11.tgz, r-oldrel (x86_64): cmprsk_2.2-11.tgz
Old sources: cmprsk archive

Reverse dependencies:

Reverse depends: APtools, cohorttools, crrstep, currentSurvival, frailtyHL, gcerisk, GFGM.copula, missDeaths
Reverse imports: DynForest, Epi, FamEvent, ggscidca, PBIR, QHScrnomo, reportRmd, riskRegression, survout, tidycmprsk
Reverse suggests: adjustedCurves, autoReg, broom, broom.helpers, Cyclops, finalfit, Greg, gtsummary, mets, mstate, pec, RcmdrPlugin.EZR, survminer

Linking:

Please use the canonical form https://CRAN.R-project.org/package=cmprsk to link to this page.

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.